EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gene Expression Profiles of AHNAK2 , DCSTAMP , FN1 , and TERT Correlate With Mutational Status and Recurrence in Papillary Thyroid Carcinoma

Julia I Staubitz-Vernazza, Celine Müller, Antonia Heymans, Annekathrin Silvia Nedwed, Mario Schindeldecker, Monika Hartmann, Michael Kloth, Arno Schad, Wilfried Roth, Thomas J Musholt, Nils Hartmann

Genes, Chromosomes and Cancer · 2024

DOI: 10.1002/gcc.23256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, 2024. Verfasst von Julia I Staubitz-Vernazza und 10 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrine Surgery, Department of General, Visceral and Transplantation Surgery, University Medical Centre, Johannes Gutenberg University M…. Hauptthemen laut MEDLINE: Telomerase, Mutation, Thyroid Cancer, Papillary, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Medical Centre of the Johannes Gutenberg University Mainz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Papillary thyroid carcinoma (PTC), the most common malignancy of follicular cell derivation, is generally associated with good prognosis. Nevertheless, it is important to identify patients with aggressive PTCs and unfavorable outcome. Molecular markers such as BRAF V600E mutation and TERT promoter mutations have been proposed for risk stratification. While TERT promoter mutations have been frequently associated with aggressive PTCs, the association of BRAF V600E mutation with increased recurrence and mortality is less clear and has been controversially discussed. The aim of the present study was to analyze whether differentially expressed genes can predict BRAF V600E mutations as well as TERT promoter mutations in PTCs. RNA sequencing identified a large number of differentially expressed genes between BRAF V600E and BRAF wildtype PTCs. Of those, AHNAK2 , DCSTAMP , and FN1 could be confirmed in a larger cohort ( n = 91) to be significantly upregulated in BRAF V600E mutant PTCs using quantitative RT‐PCR. Moreover, individual PTC expression values of DCSTAMP and FN1 were able to predict the BRAF V600E mutation status with high sensitivity and specificity. The expression of TERT was detected in all PTCs harboring TERT promoter mutations and in 19% of PTCs without TERT promoter mutations. Tumors with both TERT expression and TERT promoter mutations were particularly associated with aggressive clinicopathological features and a shorter recurrence‐free survival. Altogether, it will be interesting to explore the biological function of AHNAK2 , DCSTAMP , and FN1 in PTC in more detail. The analysis of their expression patterns could allow the characterization of PTC subtypes and thus enabling a more individualized surgical and medical treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelomeraseMutationThyroid Cancer, PapillaryNeoplasm Recurrence, LocalThyroid NeoplasmsHumansFemaleMaleMiddle AgedAdultProto-Oncogene Proteins B-rafMembrane ProteinsAgedTranscriptomeBiomarkers, TumorGene Expression Regulation, NeoplasticPromoter Regions, GeneticCytoskeletal ProteinsFibronectins

Stichwörter der Autor:innen

RNA sequencingdifferentially expressed genesmolecular markerquantitative RT‐PCRthyroid cancer

Substanzen

TelomeraseTERT protein, humanAHNAK2 protein, humanFN1 protein, humanProto-Oncogene Proteins B-rafBRAF protein, humanMembrane ProteinsBiomarkers, TumorCytoskeletal ProteinsFibronectins

Autor:innen und Institutionen

  • Section of Endocrine Surgery, Department of General, Visceral and Transplantation Surgery, University Medical Centre, Johannes Gutenberg University Mainz, Mainz, Germany.
  • Institute of Pathology, University Medical Centre, Johannes Gutenberg University Mainz, Mainz, Germany.
  • Institute for Medical Biometry, Epidemiology and Informatics, University Medical Centre Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.
  • Department of Medicine III, University Medical Centre Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.

Förderung

  • University Medical Centre of the Johannes Gutenberg University Mainz

Zitieren

APA

Staubitz-Vernazza, J. I., Müller, C., Heymans, A., Nedwed, A. S., Schindeldecker, M., Hartmann, M., Kloth, M., Schad, A., Roth, W., Musholt, T. J., & Hartmann, N. (2024). Gene Expression Profiles of AHNAK2 , DCSTAMP , FN1 , and TERT Correlate With Mutational Status and Recurrence in Papillary Thyroid Carcinoma. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.23256

Vancouver

Staubitz-Vernazza JI, Müller C, Heymans A, Nedwed AS, Schindeldecker M, Hartmann M, et al. Gene Expression Profiles of AHNAK2 , DCSTAMP , FN1 , and TERT Correlate With Mutational Status and Recurrence in Papillary Thyroid Carcinoma. Genes, Chromosomes and Cancer. 2024. doi:10.1002/gcc.23256

BibTeX
@article{StaubitzVernazza2024,
  author = {Staubitz-Vernazza, Julia I and Müller, Celine and Heymans, Antonia and Nedwed, Annekathrin Silvia and Schindeldecker, Mario and Hartmann, Monika and Kloth, Michael and Schad, Arno and Roth, Wilfried and Musholt, Thomas J and Hartmann, Nils},
  title = {Gene Expression Profiles of AHNAK2 , DCSTAMP , FN1 , and TERT Correlate With Mutational Status and Recurrence in Papillary Thyroid Carcinoma},
  journal = {Genes, Chromosomes and Cancer},
  year = {2024},
  doi = {10.1002/gcc.23256}
}
Kostenlos starten →